NKTR - Nektar Therapeutics

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue165,436230,784200,707
Cost of Revenue30,21534,10228,533
Gross Profit135,221196,682172,174
Operating Expenses
Research Development203,801182,787147,734
Selling General and Administrative44,27543,26640,925
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-112,855-29,371-16,485
Income from Continuing Operations
Total Other Income/Expenses Net2,387-12,399814
Earnings Before Interest and Taxes-110,468-41,770-15,671
Interest Expense42,18038,90138,757
Income Before Tax-152,648-80,671-54,428
Income Tax Expense876506-512
Minority Interest---
Net Income From Continuing Ops-153,524-95,256-53,916
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-153,524-81,177-53,916
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-153,524-81,177-53,916